References
- He J-L,Zhang C,Hu M-J, et al.Reproductive and menstrual factors for papillary thyroid cancer risk: acase-control study in Chinesewomen.Cancer Epidemiol.2021;73:101964.
- Links TP,Van Der Boom T,Zandee WT, et al.Cardiovascular effects of overt and subclinical hyperthyroidism: focus on differentiated thyroidcancer.Endocr Connect.2021;10(1):R43–R51.
- Hakan A,ÖZdemİR BA,Çomçali B, et al.Changes in the frequency of thyroid cancer and distribution of some subtypes in our region; Retrospective analysis of 4917thyroidectomies.Turkish J Clin Lab.2020;11(5):372–377.
- Prete A,Borges de Souza P,Censi S, et al.Update on fundamental mechanisms of thyroidcancer.Front Endocrinol (Lausanne).2020;11:102.
- Santiago K,Chen Wongworawat Y,Khan S.Differentialmicrorna-signatures in thyroid cancersubtypes.J Oncol.2020;2020. DOI:10.1155/2020/2052396
- Romei C,Elisei R.A narrative review of genetic alterations in primary thyroid epithelialcancer.Int J Mol Sci.2021;22(4):1726.
- De Leo S,Trevisan M,Fugazzola L.Recent advances in the management of anaplastic thyroidcancer.Thyroid Res.2020;13(1):1–14.
- Ghazy E,Kumar A,Barani M, et al.Scrutinizing the therapeutic and diagnostic potential of nanotechnology in thyroid cancer: edifying drug targeting bynano-oncotherapeutics.J Drug Delivery Sci Technol.2020;61,102221.
- Nies M,Cantineau AEP,Arts EGJM, et al.Long-termeffectsof radioiodine treatment on female fertility in survivors of childhood differentiated thyroidcarcinoma.Thyroid.2020;30(8):1169–1176.
- Cellini M,Rotondi M,Tanda ML, et al.Skeletal health in patients with differentiated thyroidcarcinoma.J Endocrinol Invest.2021;44(3):431–442.
- Xia Q,Wang W,Xu J, et al.Evidence from an updatedmeta-analysis of the prognostic impacts of postoperative radiotherapy and chemotherapy in patients with anaplastic thyroidcarcinoma.Onco Targets Ther.2018;11:2251.
- Li G-B,Liu G-Y,Yang J, et al.Weighted gene correlation network analysis identifies the critical longnon-coding RNAs participate in the progression ofosteosarcoma.Gen Physiol Biophys.2021;40(3):173–182.
- Meng X,Lou QY,Yang WY, et al.The role of non‐coding RNAs in drug resistance of oral squamous cell carcinoma and therapeutic potential.Cancer Commun.2021. DOI:10.1002/cac2.12194
- Mergny J-L,Riou J-F,Mailliet P, et al.Natural and pharmacological regulation oftelomerase.Nucleic Acids Res.2002;30(4):839–865.
- Saretzki G.Telomeres, telomerase andageing.Biochem Cell Biol Ageing.2018;221–308.
- Leão R,Apolónio JD,Lee D, et al.Mechanisms of human telomerase reverse transcriptase (h TERT) regulation: clinical impacts incancer.J Biomed Sci.2018;25(1):1–12.
- Rezaei Z,Sebzari A,Kordi-Tamandani DM, et al.Involvement of the dysregulation ofMir-23b-3p,Mir-195-5p,Mir-656-5p, andMir-340-5p in trastuzumab resistance ofHER2-positive breast cancer cells and system biology approach to predict their targets involved inresistance.DNA Cell Biol.2019;38(2):184–192.
- Li C,Mu J,Shi Y, et al.LncRNA CCDC26 Interacts with CELF2 protein to enhance myeloid leukemia cell proliferation and invasion via the circRNA_ANKIB1/miR-195-5p/PRR11 axis.Cell Transplant.2021;30:0963689720986080.
- Livak KJ,Schmittgen TD.Analysis of relative gene expression data using real-timequantitative PCR and the 2− ΔΔCT method.methods.2001;25(4):402–408.
- Li X,Wang Z.The role of noncoding RNA in thyroidcancer.Gland Surg.2012;1(3):146–150.
- Ikeda S,Shibata T,Funakoshi N.Immunohistochemical detection of telomerase reverse transcriptase (TERT) protein in benign and malignant tumor cells of thebreast.Jpn J Clini Pathol.2005;53(6):487–493.
- Li W,Zeng J,Li Q, et al.Reptin is required for the transcription of telomerase reverse transcriptase andover-expressed in gastriccancer.Mol Cancer.2010;9(1): 132-132.
- Esteller M.Non-codingRNAs in humandisease.Nat Rev Genet.2011;12(12):861–874.
- Stefani G,Slack FJ.Smallnon-coding RNAs in animaldevelopment.Nat Rev Mol Cell Biol.2008;9(3):219–230.
- Sun H,Huang Z,Sheng W, et al.Emerging roles of longnon-coding RNAs in tumormetabolism.J Hematol Oncol.2018;11(1):1–16.
- Li Z,Wang H,Wang Z, et al.MiR-195 inhibits the proliferation of human cervical cancer cells by directly targeting cyclinD1.Tumor Biol.2016;37(5):6457–6463.
- Zhang X,Tao T,Liu C, et al.Downregulation ofmiR-195 promotes prostate cancer progression by targetingHMGA1.Oncol Rep.2016;36(1):376–382.
- Shao Y,Li P,Zhu S, et al.Cyclooxygenase-2, a potential therapeutic target, is regulated bymiR-101 in esophageal squamous cellcarcinoma.PLOS ONE.2015;10(11):e0140642.
- Gour N,Willskarp M.IL-4 andIL-13 signaling in allergic airwaydisease.Cytokine.2015;75(1):68–78.
- Shin HS,Shon D.Food and natural materials target mechanisms to effectively regulate allergicresponses.J Nutr Sci Vitaminol (Tokyo).2015;61:109–111.
- Carr W,Bernstein JA,Lieberman P, et al.A novel intranasal therapy of azelastine with fluticasone for the treatment of allergicrhinitis.J Allergy Clin Immunol.2012;129(5):1282–1289.
- Tan Q,Qin Q,Yang W, et al.Prognostic value of Ki67 expression inHR-negative breast cancer before and after neoadjuvantchemotherapy.Int J Clin Exp Pathol.2014;7(10):6862–6870.
- Gorelik M,Frischmeyerguerrerio PA.Innate and adaptive dendritic cell responses toimmunotherapy.Curr Opin Allergy Clin Immunol.2015;15(6):575–580.
- Laino JE,Wangorsch A,Blanco F, et al.Targeting of immune cells by dual TLR2/7 ligands suppresses features of allergic Th2 immune responses inmice.Clin Dev Immunol.2017;2017: 7983217-7983217.